Articles archivés

• Volume 138 (2025)
  • Numero 1 : pp. 1-166 (January 2025)
    
• Volume 137 (2024)
  • Numero 12 : pp. 1149-1284 (December 2024)
    
  • Numero 11 : pp. 1023-1148 (November 2024)
    
  • Numero 10 : pp. 911-1022 (October 2024)
    
  • Numero 9 : pp. 791-910 (September 2024)
    
  • Numero 8 : pp. 685-790 (August 2024)
    
  • Numero 7 : pp. 559-684 (July 2024)
    
  • Numero 6 : pp. 467-558 (June 2024)
    
  • Numero 5 : pp. 379-466 (May 2024)
    
  • Numero 4 : pp. 293-378 (April 2024)
    
  • Numero 3 : pp. 187-292 (March 2024)
    
  • Numero 2 : pp. 77-186 (February 2024)
    
  • Numero 1 : pp. 1-76 (January 2024)
    

  • ---

    Numéro 2 Supplément 1, pp. S1-S42 (February 2024)
    
• Volume 136 (2023)
  • Numero 12 : pp. 1131-1224 (December 2023)
    
  • Numero 11 : pp. 1053-1130 (November 2023)
    
  • Numero 10 : pp. 949-1052 (October 2023)
    
  • Numero 9 : pp. 839-948 (September 2023)
    
  • Numero 8 : pp. 723-838 (August 2023)
    
  • Numero 7 : pp. 609-722 (July 2023)
    
  • Numero 6 : pp. 499-608 (June 2023)
    
  • Numero 5 : pp. 401-498 (May 2023)
    
  • Numero 4 : pp. 331-400 (April 2023)
    
  • Numero 3 : pp. 219-330 (March 2023)
    
  • Numero 2 : pp. 123-218 (February 2023)
    
  • Numero 1 : pp. 1-122 (January 2023)
    
• Volume 135 (2022)
  • Numero 12 : pp. 1389-1518 (December 2022)
    
  • Numero 11 : pp. 1275-1388 (November 2022)
    
  • Numero 10 : pp. 1147-1274 (October 2022)
    
  • Numero 9 : pp. 1033-1146 (September 2022)
    
  • Numero 8 : pp. 929-1032 (August 2022)
    
  • Numero 7 : pp. 799-928 (July 2022)
    
  • Numero 6 : pp. 663-798 (June 2022)
    
  • Numero 5 : pp. 543-662 (May 2022)
    
  • Numero 4 : pp. 409-542 (April 2022)
    
  • Numero 3 : pp. 269-406 (March 2022)
    
  • Numero 2 : pp. 129-268 (February 2022)
    
  • Numero 1 : pp. 1-128 (January 2022)
    

  • ---

    Supplément 1, pp. S1-S58 (April 2022)
    A Multi-Disciplinary Approach to Diagnosis and Management of Amyloidosis
• Volume 134 (2021)
  • Numero 12 : pp. 1435-1572 (December 2021)
    
  • Numero 11 : pp. 1307-1434 (November 2021)
    
  • Numero 10 : pp. 1185-1306 (October 2021)
    
  • Numero 9 : pp. 1061-1184 (September 2021)
    
  • Numero 8 : pp. 935-1060 (August 2021)
    
  • Numero 7 : pp. 825-934 (July 2021)
    
  • Numero 6 : pp. 701-824 (June 2021)
    
  • Numero 5 : pp. 557-698 (May 2021)
    
  • Numero 4 : pp. 413-556 (April 2021)
    
  • Numero 3 : pp. 295-412 (March 2021)
    
  • Numero 2 : pp. 149-294 (February 2021)
    
  • Numero 1 : pp. 1-148 (January 2021)
    
• Volume 133 (2020)
  • Numero 12 : pp. 1363-1502 (December 2020)
    
  • Numero 11 : pp. 1239-1362 (November 2020)
    
  • Numero 10 : pp. 1111-1238 (October 2020)
    
  • Numero 9 : pp. 1005-1110 (September 2020)
    
  • Numero 8 : pp. 879-1004 (August 2020)
    
  • Numero 7 : pp. 769-878 (July 2020)
    
  • Numero 6 : pp. 647-768 (June 2020)
    
  • Numero 5 : pp. 523-646 (May 2020)
    
  • Numero 4 : pp. 397-522 (April 2020)
    
  • Numero 3 : pp. 255-396 (March 2020)
    
  • Numero 2 : pp. 153-254 (February 2020)
    
  • Numero 1 : pp. 1-152 (January 2020)
    

  • ---

    Supplément 1, pp. 1-28 (May 2020)
    VTE Prophylaxis Consensus Statement supplement
• Volume 132 (2019)
  • Numero 12 : pp. 1363-1488 (December 2019)
    
  • Numero 11 : pp. 1249-1362 (November 2019)
    
  • Numero 10 : pp. 1115-1248 (October 2019)
    
  • Numero 9 : pp. 1003-1114 (September 2019)
    
  • Numero 8 : pp. A1-A12 (August 2019)
    
  • Numero 7 : pp. A1-A12 (July 2019)
    
  • Numero 6 : pp. 663-778 (June 2019)
    
  • Numero 5 : pp. 545-662 (May 2019)
    
  • Numero 4 : pp. 393-544 (April 2019)
    
  • Numero 3 : pp. 267-392 (March 2019)
    
  • Numero 2 : pp. 125-266 (February 2019)
    
  • Numero 1 : pp. 1-124 (January 2019)
    

  • ---

    Numéro 10S, pp. S1-S58 (October 2019)
    Heart failure and type 2 diabetes mellitus: exploring the role Sodium-glucose co-transporter 2 inhibitors
• Volume 131 (2018)
  • Numero 12 : pp. 1397-1528 (December 2018)
    
  • Numero 11 : pp. 1265-1396 (November 2018)
    
  • Numero 10 : pp. 1137-1264 (October 2018)
    
  • Numero 9 : pp. 989-1136 (September 2018)
    
  • Numero 8 : pp. A1-A34 (August 2018)
    
  • Numero 7 : pp. A1-A24 (July 2018)
    
  • Numero 6 : pp. A1-A16 (June 2018)
    
  • Numero 5 : pp. A1-A12 (May 2018)
    
  • Numero 4 : pp. A1-A12 (April 2018)
    
  • Numero 2 : pp. A1-A8 (February 2018)
    
  • Numero 1 : pp. A1-A6 (January 2018)
    

  • ---

    Numéro 9S, pp. 1-30 (September 2018)
    The Challenge of Controlling the COPD Epidemic
• Volume 130 (2017)
  • Numero 12 : pp. A1-A8 (December 2017)
    
  • Numero 11 : pp. A1-A10 (November 2017)
    
  • Numero 10 : pp. A1-A18 (October 2017)
    
  • Numero 9 : pp. A1-A10 (September 2017)
    
  • Numero 8 : pp. A1-A20 (August 2017)
    
  • Numero 7 : pp. A1-A8 (July 2017)
    
  • Numero 6 : pp. A1-A12 (June 2017)
    
  • Numero 5 : pp. A1-A24 (May 2017)
    
  • Numero 4 : pp. A1-A18 (April 2017)
    
  • Numero 3 : pp. A1-A18 (March 2017)
    
  • Numero 2 : pp. A1-A18 (February 2017)
    
  • Numero 1 : pp. A1-A12 (January 2017)
    

  • ---

    Numéro 6S, pp. A1-A4 (June 2017)
    Cardiovascular Disease and Sodium Glucose Cotransporter 2 Inhibitors: A New Era for Type 2 Diabetes Mellitus
• Volume 129 (2016)
  • Numero 12 : pp. A1-A30 (December 2016)
    
  • Numero 11 : pp. A1-A36 (November 2016)
    
  • Numero 10 : pp. A1-A32 (October 2016)
    
  • Numero 9 : pp. A1-A24 (September 2016)
    
  • Numero 8 : pp. A1-A28 (August 2016)
    
  • Numero 7 : pp. A1-A28 (July 2016)
    
  • Numero 6 : pp. A1-A22 (June 2016)
    
  • Numero 5 : pp. A1-A28 (May 2016)
    
  • Numero 4 : pp. A1-A18 (April 2016)
    
  • Numero 3 : pp. A1-A28 (March 2016)
    
  • Numero 2 : pp. A1-A10 (February 2016)
    
  • Numero 1 : pp. A1-A6 (January 2016)
    

  • ---

    Numéro 11S, pp. A1-A4 (November 2016)
    Reversal of Oral Anticoagulants
  • Numéro 5S, pp. A1-A8 (May 2016)
    North American Thrombosis Forum AF Action Initiative Consensus Document
• Volume 128 (2015)
  • Numero 12 : pp. A1-A6 (December 2015)
    
  • Numero 11 : pp. A1-A12 (November 2015)
    
  • Numero 10 : pp. A1-A16 (October 2015)
    
  • Numero 9 : pp. A1-A22 (September 2015)
    
  • Numero 8 : pp. A1-A16 (August 2015)
    
  • Numero 7 : pp. A1-A8 (July 2015)
    
  • Numero 6 : pp. A1-A12 (June 2015)
    
  • Numero 5 : pp. A1-A14 (May 2015)
    
  • Numero 4 : pp. A1-A12 (April 2015)
    
  • Numero 3 : pp. A1-A10 (March 2015)
    
  • Numero 2 : pp. A1-A12 (February 2015)
    
  • Numero 1 : pp. A1-A10 (January 2015)
    

  • ---

    Numéro 9S, pp. A1-A8 (September 2015)
    Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability
• Volume 127 (2014)
  • Numero 12 : pp. A1-A26 (December 2014)
    
  • Numero 11 : pp. A1-A28 (November 2014)
    
  • Numero 10 : pp. A1-A16 (October 2014)
    
  • Numero 9 : pp. A1-A14 (September 2014)
    
  • Numero 8 : pp. A1-A16 (August 2014)
    
  • Numero 7 : pp. A1-A8 (July 2014)
    
  • Numero 6 : pp. A1-A4 (June 2014)
    
  • Numero 5 : pp. A1-A8 (May 2014)
    
  • Numero 4 : pp. A1-A8 (April 2014)
    
  • Numero 3 : pp. A1-A8 (March 2014)
    
  • Numero 2 : pp. A1-A16 (February 2014)
    
  • Numero 1 : pp. A1-A18 (January 2014)
    

  • ---

    Numéro 10S, pp. A1-A8 (October 2014)
    Insulin Therapy in Type 2 Diabetes: A Reflection Upon the State of the Art Today, and the Potential Journeys yet to Come
  • Numéro 1S, pp. A1-A4 (January 2014)
    Partnership for Anaphylaxis: Enhancing Recognition, Treatment, and Outcomes
• Volume 126 (2013)
  • Numero 12 : pp. A1-A18 (December 2013)
    
  • Numero 11 : pp. A1-A12 (November 2013)
    
  • Numero 10 : pp. A1-A12 (October 2013)
    
  • Numero 9 : pp. A1-A18 (September 2013)
    
  • Numero 8 : pp. A1-A16 (August 2013)
    
  • Numero 7 : pp. A1-A16 (July 2013)
    
  • Numero 6 : pp. A1-A14 (June 2013)
    
  • Numero 5 : pp. A1-A10 (May 2013)
    
  • Numero 4 : pp. A1-A8 (April 2013)
    
  • Numero 3 : pp. A1-A10 (March 2013)
    
  • Numero 2 : pp. A1-A8 (February 2013)
    
  • Numero 1 : pp. A1-A6 (January 2013)
    

  • ---

    Numéro 10 Supplément 1, pp. A1-A4 (October 2013)
    Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations
  • Numéro 9 Supplément 1, pp. A1-A4 (September 2013)
    Changing Patterns in the Treatment of Type 2 Diabetes
  • Numéro 3 Supplément 1, pp. A1-A4 (March 2013)
    Opioids in Chronic Pain: Evolving Best Practice Strategies
• Volume 125 (2012)
  • Numero 12 : pp. A1-A10 (December 2012)
    
  • Numero 11 : pp. A1-A26 (November 2012)
    
  • Numero 10 : pp. A1-A14 (October 2012)
    
  • Numero 9 : pp. A1-A30 (September 2012)
    
  • Numero 8 : pp. A1-A24 (August 2012)
    
  • Numero 7 : pp. A1-A30 (July 2012)
    
  • Numero 6 : pp. A1-A24 (June 2012)
    
  • Numero 5 : pp. A1-A26 (May 2012)
    
  • Numero 4 : pp. A1-A18 (April 2012)
    
  • Numero 3 : pp. A1-A12 (March 2012)
    
  • Numero 2 : pp. A1-A12 (February 2012)
    
  • Numero 1 : pp. A1-A12 (January 2012)
    

  • ---

    Numéro 7S, pp. A1-A4 (July 2012)
    Myelodysplastic Syndromes
  • Numéro 1S, pp. S1-S58 (January 2012)
    Invasive Mycoses: Evolving Challenges and Opportunities in Antifungal Therapy
• Volume 124 (2011)
  • Numero 12 : pp. A1-A12 (December 2011)
    
  • Numero 11 : pp. A1-A6 (November 2011)
    
  • Numero 10 : pp. A1-A6 (October 2011)
    
  • Numero 9 : pp. A1-A8 (September 2011)
    
  • Numero 8 : pp. A1-A6 (August 2011)
    
  • Numero 7 : pp. A1-A6 (July 2011)
    
  • Numero 6 : pp. A1-A8 (June 2011)
    
  • Numero 5 : pp. A1-A12 (May 2011)
    
  • Numero 4 : pp. A1-A10 (April 2011)
    
  • Numero 3 : pp. A1-A8 (March 2011)
    
  • Numero 2 : pp. A1-A12 (February 2011)
    
  • Numero 1 : pp. A1-A10 (January 2011)
    

  • ---

    Numéro 10S, pp. A1-A8 (October 2011)
    Challenges and Opportunities in the Management of the Hispanic/Latino Patient With Type 2 Diabetes Mellitus
  • Numéro 4S, pp. A1-A8 (April 2011)
    Shared Experiences and Best Practices in the Management of Rheumatoid Arthritis and Crohn's Disease
  • Numéro 1S, pp. S1-S64 (January 2011)
    Exploring the Spectrum of Incretin Therapies: The Potential for Optimizing Patient Outcomes
• Volume 123 (2010)
  • Numero 11 : pp. A1-A14 (November 2010)
    
  • Numero 10 : pp. A1-A12 (October 2010)
    
  • Numero 8 : pp. A1-A12 (August 2010)
    
  • Numero 7 : pp. A1-A10 (July 2010)
    
  • Numero 3 : pp. A1-A10 (March 2010)
    
  • Numero 2 : pp. A1-A8 (February 2010)
    
  • Numero 1 : pp. A1-A16 (January 2010)
    

  • ---

    Numéro 12S, pp. A1-A6 (December 2010)
    Comparative Effectiveness Research-Objectives, Challenges, and Contributions of the US Department of Veterans Affairs
  • Numéro 3S, pp. S1-S50 (March 2010)
    Current Issues in the Treatment of Type 2 Diabetes
• Volume 122 (2009)
  • Numero 12 : pp. A1-A20 (December 2009)
    
  • Numero 11 : pp. A1-A16 (November 2009)
    
  • Numero 10 : pp. A1-A12 (October 2009)
    
  • Numero 9 : pp. A1-A12 (September 2009)
    
  • Numero 8 : pp. A1-A12 (August 2009)
    
  • Numero 7 : pp. A1-A16 (July 2009)
    
  • Numero 6 : pp. A1-A14 (June 2009)
    
  • Numero 5 : pp. A1-A12 (May 2009)
    
  • Numero 4 : pp. A1-A14 (April 2009)
    
  • Numero 3 : pp. A1-A8 (March 2009)
    
  • Numero 2 : pp. A1-A8 (February 2009)
    
  • Numero 1 : pp. A1-A8 (January 2009)
    

  • ---

    Numéro 12S, pp. S1-S58 (December 2009)
    Fibromyalgia-The Evolution of New Treatment Strategies for Improving Patient Care
  • Numéro 10S, pp. S1-S38 (October 2009)
    Recommendations for the Definition, Assessment, and Pharmacologic Management of Neuropathic Pain
  • Numéro 8S, pp. S1-S34 (August 2009)
    Understanding Human Papillomavirus, Cervical Cancer, and Vaccines: an Educational Resource for Family and General Practitioners
  • Numéro 6S, pp. S1-S50 (June 2009)
    Demystifying Incretin Therapy for Type 2 Diabetes
  • Numéro 5S, pp. S1-S26 (May 2009)
    The Potential Role of Nitric Oxide in Cardiovascular Safety when Treating Osteoarthritis in Patients with Hypertension
  • Numéro 4 Supplément 2, pp. S1-S34 (April 2009)
    Role of the Primary Care Physician in Stroke Prevention
  • Numéro 4S, pp. S1-S46 (April 2009)
    The Obesity Epidemic: Strategies in Reducing Cardiometabolic Risk
  • Numéro 2S, pp. S1-S48 (February 2009)
    Clinical Issues with Bisphosphonate Therapy for Osteoporosis
  • Numéro 1S, pp. S1-S64 (January 2009)
    Management of Atherosclerosis: A Practical Guide in 2008
• Volume 121 (2008)
  • Numero 12 : pp. A1-A10 (December 2008)
    
  • Numero 11 : pp. A1-A14 (November 2008)
    
  • Numero 10 : pp. A1-A10 (October 2008)
    
  • Numero 9 : pp. A1-A10 (September 2008)
    
  • Numero 8 : pp. A1-A12 (August 2008)
    
  • Numero 7 : pp. A1-A12 (July 2008)
    
  • Numero 6 : pp. A1-A10 (June 2008)
    
  • Numero 5 : pp. A1-A14 (May 2008)
    
  • Numero 4 : pp. A1-A12 (April 2008)
    
  • Numero 3 : pp. A1-A10 (March 2008)
    
  • Numero 2 : pp. A1-A12 (February 2008)
    
  • Numero 1 : pp. A1-A14 (January 2008)
    

  • ---

    Numéro 12S, pp. S1-S62 (December 2008)
    Optimizing Management Strategies in Patients with Chronic Hepatitis B
  • Numéro 11 Supplément 2, pp. S1-S48 (November 2008)
    A Primary Care Approach: Managing Depression in the Face of Chronic Medical Conditions
  • Numéro 11 Supplément 1, pp. S1-S42 (November 2008)
    Venous Thromboembolism 2008: The Changing Paradigm of Deep Vein Thrombosis and Pulmonary Embolism Prophylaxis and Treatment
  • Numéro 10 Supplément 1, pp. S1-S34 (October 2008)
    Heightened Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis
  • Numéro 8 Supplément 2, pp. S1-S42 (August 2008)
    Optimizing the Treatment of Benign Prostatic Hyperplasia in African American and Latin American Men
  • Numéro 8 Supplément 1, pp. S1-S34 (August 2008)
    Management of Hypertension in Patients with Enhanced Cardiovascular Risk
  • Numéro 7 Supplément 2, pp. S1-S38 (July 2008)
    Expanding the Influenza Vaccination Season: A New Paradigm for Increasing Immunization Rates
  • Numéro 7 Supplément 1, pp. S1-S46 (July 2008)
    Early Identification and Active Management of the Patient with Chronic Obstructive Pulmonary Disease
  • Numéro 6S, pp. S1-S42 (June 2008)
    Optimizing Insulin Therapy for Type 2 Diabetes Mellitus
  • Numéro 5S, pp. S1-S48 (May 2008)
    Diagnostic Error: Is Overconfidence the Problem
  • Numéro 4S, pp. S1-S42 (April 2008)
    Update on Smoking Cessation Interventions for the Primary Care Physician
• Volume 120 (2007)
  • Numero 12 : pp. A1-A20 (December 2007)
    
  • Numero 11 : pp. A1-A18 (November 2007)
    
  • Numero 10 : pp. A1-A28 (October 2007)
    
  • Numero 9 : pp. A1-A26 (September 2007)
    
  • Numero 8 : pp. A1-A32 (August 2007)
    
  • Numero 7 : pp. A1-A28 (July 2007)
    
  • Numero 6 : pp. A1-A18 (June 2007)
    
  • Numero 5 : pp. A1-A18 (May 2007)
    
  • Numero 4 : pp. A1-A18 (April 2007)
    
  • Numero 3 : pp. A1-A26 (March 2007)
    
  • Numero 2 : pp. A1-A26 (February 2007)
    
  • Numero 1 : pp. e1-e22 (January 2007)
    

  • ---

    Numéro 11 Supplément 1, pp. S1-S22 (November 2007)
    Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations
  • Numéro 10 Supplément 2, pp. S1-S42 (October 2007)
    Management of Venous Thromboembolism
  • Numéro 10 Supplément 1, pp. S1-S34 (October 2007)
    Early Clinical Experiences with Daptomycin for the Treatment of Gram-Positive Infections
  • Numéro 9 Supplément 2, pp. S1-S40 (September 2007)
    Optimizing Cardiovascular Outcomes in Diabetes Mellitus: A Call to Action
  • Numéro 9 Supplément 1, pp. S1-S40 (September 2007)
    Managing Cardiometabolic Risk: Will New Approaches Improve Success?
  • Numéro 8 Supplément 1, pp. S1-S40 (August 2007)
    Creating Optimism in Managing Chronic Obstructive Pulmonary Disease
  • Numéro 4 Supplément 1, pp. S1-S38 (April 2007)
    Science Policy Roundtable on the Heterogeneity of Treatment Effects
  • Numéro 3 Supplément 1, pp. S1-S42 (March 2007)
    Modifying Cardiovascular and Metabolic Risk Factors: The Role of the Endocannabinoid System and Cannabinoid Receptors
  • Numéro 2 Supplément 1, pp. S1-S40 (February 2007)
    Targeting Abdominal Obesity to Reduce Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus
  • Numéro 1 Supplément 1, pp. S1-S36 (January 2007)
    Recognizing and Treating Restless Legs Syndrome: Current Standards
• Volume 119 (2006)
  • Numero 12 : pp. e1-e34 (December 2006)
    
  • Numero 11 : pp. e1-e10 (November 2006)
    
  • Numero 10 : pp. e1-e4 (October 2006)
    
  • Numero 9 : pp. 715-810 (September 2006)
    
  • Numero 8 : pp. e1-e10 (August 2006)
    
  • Numero 7 : pp. e1-e20 (July 2006)
    
  • Numero 6 : pp. e1-e16 (June 2006)
    
  • Numero 5 : pp. e1-e26 (May 2006)
    
  • Numero 4 : pp. e1-e16 (April 2006)
    
  • Numero 3 : pp. e1-e19 (March 2006)
    
  • Numero 2 : pp. 101-192 (February 2006)
    
  • Numero 1 : pp. 1-100 (January 2006)
    

  • ---

    Numéro 12 Supplément 1, pp. S1-S44 (December 2006)
    Treatment of Congestion in Acute Heart Failure Syndromes: Importance, Strategies, and Challenges
  • Numéro 11 Supplément 1, pp. S1-S34 (November 2006)
    Case Studies in Gouty Arthritis
  • Numéro 10 Supplément 1, pp. 1-72 (October 2006)
    The Role of Patient-Centered Outcomes in Defining the Clinical Course of Chronic Obstructive Pulmonary Disease
  • Numéro 9 Supplément 1, pp. S1-S112 (September 2006)
    Genetics and the Sex Steroid Hormone Pathway in Women at Midlife
  • Numéro 7 Supplément 1, pp. 1-100 (July 2006)
    Hyponatremia: New Understanding, New Therapy
  • Numéro 6 Supplément 1, pp. S1-S76 (June 2006)
    Antimicrobial Resistance Prevention Initiative: Proceedings of an Expert Panel on Resistance
  • Numéro 5 Supplément 1, pp. S1-S50 (May 2006)
    A New Dawn in Cardiovascular Protection III: The Challenge of End-Organ Protection in High-Risk Patients
  • Numéro 4 Supplément 1, pp. S1-S38 (April 2006)
    Improving Compliance and Persistence with Osteoporosis Therapies
  • Numéro 3 Supplément 1, pp. 1-40 (March 2006)
    Overactive Bladder: Issues and Management
• Volume 118 (2005)
  • Numero 12 : pp. 1311-1480 (December 2005)
    
  • Numero 11 : pp. 1181-1310 (November 2005)
    
  • Numero 10 : pp. 1061-1180 (October 2005)
    
  • Numero 9 : pp. 935-1060 (September 2005)
    
  • Numero 8 : pp. 807-934 (August 2005)
    
  • Numero 7 : pp. 693-806 (July 2005)
    
  • Numero 6 : pp. 569-692 (June 2005)
    
  • Numero 5 : pp. 449-568 (May 2005)
    
  • Numero 4 : pp. i-viii (April 2005)
    
  • Numero 3 : pp. 203-324 (March 2005)
    
  • Numero 2 : pp. 99-202 (February 2005)
    
  • Numero 1 : pp. 1-98 (January 2005)
    

  • ---

    Numéro 12 Supplément 2, pp. 1-172 (December 2005)
    The NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms March 21-23, 2005
  • Numéro 12S, pp. 1-68 (December 2005)
    Statin Therapy: Clinical Trials, Guidelines, and New Directions
  • Numéro 10S, pp. 1-108 (October 2005)
    Vaccine-Preventable Hepatitis, a Step Toward Elimination: Reevaluating Hepatitis A and B Prevention
  • Numéro 9S, pp. 1-32 (September 2005)
    The Role of Self Monitoring of Blood Glucose in the Care of People with Diabetes: Report of a Global Consensus Conference
  • Numéro 8S, pp. 1-36 (August 2005)
    Venous Thromboembolic Disease
  • Numéro 7S, pp. 1-50 (July 2005)
    Recommendations for Accurate Prescribing of Antibiotics: Council for Appropriate and Rational Antibiotic Therapy
  • Numéro 5S, pp. 1-34 (May 2005)
    Pharmacologic Treatment of Type 2 Diabetes Mellitus
• Volume 117 (2004)
  • Numero 12 : pp. 897-1010 (December 2004)
    
  • Numero 11 : pp. 811-896 (December 2004)
    
  • Numero 10 : pp. 719-810 (November 2004)
    
  • Numero 9 : pp. 629-718 (November 2004)
    
  • Numero 8 : pp. 541-628 (October 2004)
    
  • Numero 7 : pp. 451-540 (October 2004)
    
  • Numero 6 : pp. 371-450 (September 2004)
    
  • Numero 5 : pp. 291-370 (September 2004)
    
  • Numero 4 : pp. 219-290 (August 2004)
    
  • Numero 3 : pp. 145-218 (August 2004)
    
  • Numero 2 : pp. 73-144 (July 2004)
    
  • Numero 1 : pp. 1-72 (July 2004)
    
• Volume 116 (2004)
  • Numero 12 : pp. 797-888 (June 2004)
    
  • Numero 11 : pp. 725-796 (June 2004)
    
  • Numero 10 : pp. 651-724 (May 2004)
    
  • Numero 9 : pp. 581-650 (May 2004)
    
  • Numero 8 : pp. 509-580 (April 2004)
    
  • Numero 7 : pp. 435-508 (April 2004)
    
  • Numero 6 : pp. 363-434 (March 2004)
    
  • Numero 5 : pp. 291-362 (March 2004)
    
  • Numero 4 : pp. 217-290 (February 2004)
    
  • Numero 3 : pp. 145-216 (February 2004)
    
  • Numero 2 : pp. 73-144 (January 2004)
    
  • Numero 1 : pp. 1-72 (January 2004)
    

  • ---

    Numéro 7 Supplément 1, pp. 1-70 (April 2004)
    
  • Numéro 6 Supplément 1, pp. 1-36 (March 2004)
    
  • Numéro 5 Supplément 1, pp. 1-98 (March 2004)
    
  • Numéro 3 Supplément 1, pp. 1-22 (February 2004)
    
• Volume 115 (2003)
  • Numero 9 : pp. 689-772 (December 2003)
    
  • Numero 8 : pp. 601-688 (December 2003)
    
  • Numero 7 : pp. 515-600 (November 2003)
    
  • Numero 6 : pp. 429-514 (October 2003)
    
  • Numero 5 : pp. A1-A6 (October 2003)
    
  • Numero 4 : pp. 259-342 (September 2003)
    
  • Numero 3 : pp. 171-258 (August 2003)
    
  • Numero 2 : pp. 85-170 (August 2003)
    
  • Numero 1 : pp. 1-84 (July 2003)
    

  • ---

    Numéro 8 Supplément 1, pp. 1-120 (December 2003)
    Evaluating the Cardiovascular Effects of the Thiazolidinediones and Their Place in the Management of Type 2 Diabetes Mellitus
  • Numéro 3 Supplément 1, pp. 1-218 (August 2003)
    
• Volume 114 (2003)
  • Numero 9 : pp. 715-800 (June 2003)
    
  • Numero 8 : pp. 625-714 (June 2003)
    
  • Numero 7 : pp. 521-624 (May 2003)
    
  • Numero 6 : pp. 431-520 (April 2003)
    
  • Numero 5 : pp. 347-430 (April 2003)
    
  • Numero 4 : pp. A1-A6 (March 2003)
    
  • Numero 3 : pp. 173-256 (February 2003)
    
  • Numero 2 : pp. A1-A6 (February 2003)
    
  • Numero 1 : pp. A1-A10 (January 2003)
    
• Volume 113 (2002)
  • Numero 9 : pp. A1-A4 (December 2002)
    
  • Numero 8 : pp. A1-A6 (December 2002)
    
  • Numero 7 : pp. A1-A6 (November 2002)
    
  • Numero 6 : pp. A1-A6 (October 2002)
    
  • Numero 5 : pp. A1-A4 (October 2002)
    
  • Numero 4 : pp. A1-A4 (September 2002)
    
  • Numero 3 : pp. A1-A6 (August 2002)
    
  • Numero 2 : pp. A1-A6 (August 2002)
    
  • Numero 1 : pp. A1-A5 (July 2002)
    

  • ---

    Numéro 9 Supplément 2, pp. 1-106 (December 2002)
    
  • Numéro 9 Supplément 1, pp. 1-64 (December 2002)
    
  • Numéro 6S, pp. 1-50 (October 2002)
    
  • Numéro 1 Supplément 1, pp. 1-84 (July 2002)
    
• Volume 112 (2002)
  • Numero 9 : pp. A1-A4 (June 2002)
    
  • Numero 8 : pp. A1-A6 (June 2002)
    
  • Numero 7 : pp. A1-A4 (May 2002)
    
  • Numero 6 : pp. A1-A5 (April 2002)
    
  • Numero 5 : pp. A1-A7 (April 2002)
    
  • Numero 4 : pp. A1-A4 (March 2002)
    
  • Numero 3 : pp. A1-A6 (February 2002)
    
  • Numero 2 : pp. A1-A6 (February 2002)
    
  • Numero 1 : pp. A1-A8 (January 2002)
    

  • ---

    Numéro 8 Supplément 1, pp. 1-42 (June 2002)
    Atherosclerotic Cardiovascular Disease: New Approaches to Risk Assessment and Intervention
  • Numéro 6 Supplément 1, pp. 1-50 (April 2002)
    The Emerging Importance of Rhinoviral Respiratory Infections
• Volume 111 (2001)
  • Numero 9 : pp. A1-A4 (December 2001)
    
  • Numero 8 : pp. A1-A6 (December 2001)
    
  • Numero 7 : pp. A1-A5 (November 2001)
    
  • Numero 6 : pp. A1-A6 (October 2001)
    
  • Numero 5 : pp. 341-432 (October 2001)
    
  • Numero 4 : pp. 255-340 (September 2001)
    
  • Numero 3 : pp. A1-A10 (August 2001)
    
  • Numero 2 : pp. A1-A8 (August 2001)
    
  • Numero 1 : pp. 1-88 (July 2001)
    

  • ---

    Numéro 9 Supplément 2, pp. i-iv (December 2001)
    The Patient-Provider Relationship and the Hospitalist Movement
  • Numéro 9 Supplément 1, pp. 1-42 (December 2001)
    Respiratory Pathogens in the Community: Prevalence and Treatment
  • Numéro 8 Supplément 1, pp. 1-220 (December 2001)
    Third Multi-Disciplinary International Symposium on Supraesophageal Complications of Reflux Disease
• Volume 110 (2001)
  • Numero 9 : pp. A1-A10 (June 2001)
    
  • Numero 8 : pp. A1-A12 (June 2001)
    
  • Numero 7 : pp. A1-A6 (May 2001)
    
  • Numero 6 : pp. A1-A6 (April 2001)
    
  • Numero 5 : pp. A1-A6 (April 2001)
    
  • Numero 4 : pp. A1-A6 (March 2001)
    
  • Numero 3 : pp. A1-A6 (February 2001)
    
  • Numero 2 : pp. A1-A4 (February 2001)
    
  • Numero 1 : pp. A1-A6 (January 2001)
    

  • ---

    Numéro 7 Supplément 1, pp. i-x (May 2001)
    Use of Beta-Blocker Therapy for Mild-to-Moderate Chronic Heart Failure
  • Numéro 6 Supplément 1, pp. 1-34 (April 2001)
    Reaching National Cholesterol Goals: A Managed Care Approach to Improving Hyperlipidemia Disease Management Outcomes
  • Numéro 5 Supplément 1, pp. 1-20 (April 2001)
    
  • Numéro 3 Supplément 1, pp. 1-56 (February 2001)
    The Role of COX-2-Specific Inhibitors in Clinical Practice
  • Numéro 1 Supplément 1, pp. S1-S100 (January 2001)
    Nonsteroidal Anti-Inflammatory Drugs and the Gastrointestinal Tract: Consensus and Controversy
• Volume 109 (2000)
  • Numero 9 : pp. A1-A6 (December 2000)
    
  • Numero 8 : pp. A1-A4 (December 2000)
    
  • Numero 7 : pp. A1-A6 (November 2000)
    
  • Numero 6 : pp. A1-A8 (October 2000)
    
  • Numero 5 : pp. A1-A4 (October 2000)
    
  • Numero 4 : pp. A1-A12 (September 2000)
    
  • Numero 3 : pp. A1-A10 (August 2000)
    
  • Numero 2 : pp. A1-A10 (August 2000)
    
  • Numero 1 : pp. A1-A10 (July 2000)
    

  • ---

    Numéro 9 Supplément 1, pp. 1-34 (December 2000)
    New Perspectives on Managing Erectile Dysfunction in Primary Care
• Volume 108 (2000)
  • Numero 9 : pp. A1-A6 (June 2000)
    
  • Numero 8 : pp. A1-A10 (June 2000)
    
  • Numero 7 : pp. A1-A10 (May 2000)
    
  • Numero 6 : pp. A1-A10 (April 2000)
    
  • Numero 5 : pp. A1-A10 (April 2000)
    
  • Numero 4 : pp. A1-A6 (March 2000)
    
  • Numero 3 : pp. 187-268 (February 2000)
    
  • Numero 2 : pp. A1-A8 (February 2000)
    
  • Numero 1 : pp. 1-98 (January 2000)
    

  • ---

    Numéro 6 Supplément 1, pp. 1-34 (April 2000)
    
  • Numéro 4 Supplément 1, pp. 1-208 (March 2000)
    
• Volume 107 (1999)
  • Numero 6 : pp. A1-A8 (December 1999)
    
  • Numero 5 : pp. 409-536 (November 1999)
    
  • Numero 4 : pp. A1-A6 (October 1999)
    
  • Numero 3 : pp. 193-304 (September 1999)
    
  • Numero 2 : pp. 109-192 (August 1999)
    
  • Numero 1 : pp. 1-108 (July 1999)
    

  • ---

    Numéro 6 Supplément 2, pp. 1-104 (December 1999)
    
  • Numéro 6 Supplément 1, pp. 1-90 (December 1999)
    
  • Numéro 5 Supplément 1, pp. 1-104 (November 1999)
    
  • Numéro 2 Supplément 2, pp. 1-42 (August 1999)
    
  • Numéro 2 Supplément 1, pp. 1-56 (August 1999)
    
  • Numéro 1 Supplément 1, pp. 1-90 (July 1999)
    
• Volume 106 (1999)
  • Numero 6 : pp. 601-708 (June 1999)
    
  • Numero 5 : pp. 493-600 (May 1999)
    
  • Numero 4 : pp. 381-492 (April 1999)
    
  • Numero 3 : pp. 269-380 (March 1999)
    
  • Numero 2 : pp. 127-268 (February 1999)
    
  • Numero 1 : pp. 1-126 (January 1999)
    

  • ---

    Numéro 5 Supplément 2, pp. 1S-58S (May 1999)
    
  • Numéro 5 Supplément 1, pp. 1-52 (May 1999)
    
  • Numéro 1 Supplément 1, pp. 1-52 (January 1999)
    
• Volume 105 (1998)
  • Numero 6 : pp. 459-568 (December 1998)
    
  • Numero 5 : pp. 363-458 (November 1998)
    
  • Numero 4 : pp. 259-362 (October 1998)
    
  • Numero 3 : pp. 173-258 (September 1998)
    
  • Numero 2 : pp. 87-172 (August 1998)
    
  • Numero 1 : pp. 1-86 (July 1998)
    

  • ---

    Numéro 5 Supplément 1, pp. 1S-52S (November 1998)
    
  • Numéro 3 Supplément 1, pp. 1S-124S (September 1998)
    
  • Numéro 1 Supplément 2, pp. 1S-60S (July 1998)
    
  • Numéro 1 Supplément 1, pp. 1S-82S (July 1998)
    
• Volume 104 (1998)
  • Numero 6 : pp. 511-620 (June 1998)
    
  • Numero 5 : pp. 409-510 (May 1998)
    
  • Numero 4 : pp. 323-408 (April 1998)
    
  • Numero 3 : pp. 215-322 (March 1998)
    
  • Numero 2 : pp. 109-214 (February 1998)
    
  • Numero 1 : pp. 1-108 (January 1998)
    

  • ---

    Numéro 6 Supplément 1, pp. 1S-60S (June 1998)
    
  • Numéro 5 Supplément 1, pp. 1S-42S (May 1998)
    
  • Numéro 4 Supplément 1, pp. 1S-42S (April 1998)
    
  • Numéro 3 Supplément 1, pp. 1S-96S (March 1998)
    
  • Numéro 2 Supplément 1, pp. 1S-34S (February 1998)
    
• Volume 103 (1997)
  • Numero 6 : pp. 451-558 (December 1997)
    
  • Numero 5 : pp. 337-450 (November 1997)
    
  • Numero 4 : pp. 253-336 (October 1997)
    
  • Numero 3 : pp. 173-252 (September 1997)
    
  • Numero 2 : pp. 87-172 (August 1997)
    
  • Numero 1 : pp. A1-A10 (July 1997)
    

  • ---

    Numéro 6 Supplément 1, pp. S1-S85 (December 1997)
    
  • Numéro 5 Supplément 1, pp. 1S-152S (November 1997)
    
  • Numéro 3 Supplément 1, pp. 1-50 (September 1997)
    
  • Numéro 2 Supplément 1, pp. S1-S92 (August 1997)
    Advances in the Epidemiology, Prevention, and Treatment of Osteoporosis and Fractures
• Volume 102 (1997)
  • Numero 6 : pp. 507-601 (June 1997)
    
  • Numero 5 : pp. 427-506 (May 1997)
    
  • Numero 4 : pp. 323-426 (April 1997)
    
  • Numero 3 : pp. 223-322 (March 1997)
    
  • Numero 2 : pp. 133-222 (February 1997)
    
  • Numero 1 : pp. 1-132 (January 1997)
    

  • ---

    Numéro 5 Supplément 3, pp. 1-55 (May 1997)
    
  • Numéro 5 Supplément 2, pp. 1-126 (May 1997)
    
  • Numéro 5 Supplément 1, pp. 1-43 (May 1997)
    
  • Numéro 4 Supplément 1, pp. 1-30 (April 1997)
    
  • Numéro 3 Supplément 1, pp. 1-88 (March 1997)
    
  • Numéro 2 Supplément 1, pp. 1-56 (February 1997)
    
  • Numéro 1 Supplément 1, pp. 1S-42S (January 1997)
    
• Volume 101 (1996)
  • Numero 6 : pp. 571-676 (December 1996)
    
  • Numero 5 : pp. 449-570 (November 1996)
    
  • Numero 4 : pp. 331-448 (October 1996)
    
  • Numero 3 : pp. 241-330 (September 1996)
    
  • Numero 2 : pp. 123-239 (August 1996)
    
  • Numero 1 : pp. 1-119 (July 1996)
    

  • ---

    Numéro 6 Supplément 1, pp. 1S-56S (December 1996)
    
  • Numéro 4 Supplément 1, pp. 1S-83S (October 1996)
    
  • Numéro 3 Supplément 1, pp. 1S-92S (September 1996)
    
  • Numéro 2 Supplément 1, pp. 1S-44S (August 1996)
    
  • Supplément 1, pp. S1-S63 (July 1996)
    
• Volume 100 (1996)
  • Numero 6 : pp. 589-678 (June 1996)
    
  • Numero 5 : pp. 485-588 (May 1996)
    
  • Numero 4 : pp. 375-482 (April 1996)
    
  • Numero 3 : pp. 251-374 (March 1996)
    
  • Numero 2 : pp. 123-249 (February 1996)
    
  • Numero 1 : pp. A1-A8 (January 1996)
    

  • ---

    Numéro 6 Supplément 1, pp. 1S-95S (June 1996)
    is 6A
  • Numéro 2 Supplément 1, pp. 1S-52S (February 1996)
    
  • Supplément 1, pp. S1-S70 (January 1996)
    Obstructive Airways Disease: Antimuscarinic Bronchodilator therapy
• Volume 99 (1995)
  • Numero 6 : pp. A11-A14 (December 1995)
    
  • Numero 5 : pp. 451-578 (November 1995)
    
  • Numero 4 : pp. A13-A16 (October 1995)
    
  • Numero 3 : pp. A13-A16 (September 1995)
    
  • Numero 2 : pp. 111-226 (August 1995)
    
  • Numero 1 : pp. A19-A22 (July 1995)
    

  • ---

    Numéro 6 Supplément 1, pp. 1S-92s (December 1995)
    
• Volume 98 (1995)
  • Numero 6 : pp. 521-614 (June 1995)
    
  • Numero 5 : pp. 425-520 (May 1995)
    
  • Numero 4 : pp. 321-424 (April 1995)
    
  • Numero 3 : pp. 217-320 (March 1995)
    
  • Numero 2 : pp. 105-215 (February 1995)
    
  • Numero 1 : pp. 1-103 (January 1995)
    

  • ---

    Numéro 4 Supplément 1, pp. 1S-89S (April 1995)
    National Clinical Conference on Lyme Disease
  • Numéro 2 Supplément 1, pp. 1S-88S (February 1995)
    Proceedings of a Symposium Osteoporosis: Who Should be Treated?
  • Numéro 1 Supplément 1, pp. S1-S143 (January 1995)
    
• Volume 84 (1988)

  • ---

    Supplément 1, pp. 1-111 (January 1988)
    Well-Being, Hypertension, and Indapamide Proceedings of the XVth International Meeting
• Volume 75 (1983)
  • Numero 6 : pp. A3-A48 (December 1983)
    
  • Numero 4 : pp. A3-A44 (October 1983)
    
• Volume 73 (1982)
  • Numero 3 : pp. 301-459 (September 1982)
    
• Volume 71 (1981)
  • Numero 6 : pp. A2-A32 (December 1981)
    
  • Numero 5 : pp. A2-A32 (November 1981)
    
• Volume 70 (1981)
  • Numero 4 : pp. A29-A70 (April 1981)
    
• Volume 68 (1980)
  • Numero 1 : pp. A3-A32 (January 1980)
    
• Volume 61 (1976)
  • Numero 6 : pp. A1-A31 (December 1976)
    
• Volume 59 (1975)
  • Numero 5 : pp. A1-A48 (November 1975)
    
• Volume 58 (1975)
  • Numero 3 : pp. A1-A44 (March 1975)
    
• Volume 57 (1974)
  • Numero 4 : pp. A1-A52 (October 1974)
    
  • Numero 1 : pp. A1-A24 (July 1974)
    Third F. Raymond Keating, Jr., Memorial Symposium-Parathyroid Hormone, Calcitonin and Vitamin D: Clinical Considerations (Part II)
• Volume 56 (1974)
  • Numero 6 : pp. A1-A6 (June 1974)
    Third F. Raymond Keating, Jr., Memorial Symposium\3-Parathyroid Hormone, Calcitonin and Vitamin D: Clinical Considerations (Part I)
• Volume 55 (1973)
  • Numero 1 : pp. A1-A21 (July 1973)
    
• Volume 54 (1973)
  • Numero 1 : pp. A1-A28 (January 1973)
    
• Volume 52 (1972)
  • Numero 1 : pp. A1-A2 (January 1972)
    
• Volume 38 (1965)
  • Numero 1 : pp. A2-A92 (January 1965)
    
• Volume 35 (1963)
  • Numero 1 : pp. A3-A66 (July 1963)
    
• Volume 25 (1958)
  • Numero 1 : pp. A1-A64 (July 1958)
    
• Volume 23 (1957)
  • Numero 4 : pp. 507-672 (October 1957)
    
  • Numero 2 : pp. 163-332 (August 1957)
    
• Volume 22 (1957)
  • Numero 1 : pp. A1-A64 (January 1957)
    
• Volume 21 (1956)
  • Numero 1 : pp. A2-A64 (July 1956)
    
• Volume 20 (1956)
  • Numero 6 : pp. A3-A64 (June 1956)